Welcome to our dedicated page for Afya news (Ticker: AFYA), a resource for investors and traders seeking the latest updates and insights on Afya stock.
Afya Limited reports financial, regulatory and capital-allocation developments for a Brazil-based medical education group and medical practice solutions provider. The company serves medical students and physicians through an end-to-end ecosystem that includes undergraduate medical education, residency preparation, continuing medical education, graduate programs and practice-management solutions.
Recurring company developments include IFRS financial results in Brazilian reais, medical-seat authorizations from Brazil’s Ministry of Education, campus-level capacity changes, credit-rating actions, dividends, share repurchases and board changes. Afya also reports activity in continuing education, B2B revenue, clinical management tools and the broader physician base that uses its education and medical practice platforms.
Afya Limited (NASDAQ: AFYA) is set to hold its Annual General Meeting (AGM) on April 29, 2022, at 11:00 AM Brasília time, both in-person and virtually. Key resolutions include the approval of the financial statements for the fiscal year ended December 31, 2021, and amendments to the Memorandum and Articles of Association following a transaction with Bertelsmann SE & Co. KGaA. Shareholders on record as of April 7, 2022, are eligible to participate and vote. The company emphasizes the importance of shareholder participation in decision-making.
Summary not available.
Afya Limited (NASDAQ: AFYA) has announced the acquisition of 100% of CardioPapers for an enterprise value of R$35.0 million, paid in cash. CardioPapers is a leading medical content and education platform in Cardiology, offering over ten courses and engaging nearly 215,000 followers on Instagram. The platform generated R$18.8 million in gross revenue for 2022. Additional earn-out payments of up to R$15 million may be made based on revenue and other goals for 2023 and 2024. This acquisition is expected to enhance Afya's digital ecosystem and capabilities in medical education.
Afya Limited (NASDAQ: AFYA) delivered strong financial results for FY21, with adjusted net revenue rising 45.1% YoY to R$1,752.7 million. The company's adjusted EBITDA grew 34.0% YoY to R$754.8 million, resulting in an EBITDA margin of 43.1%. In Q4 2021, adjusted net revenue reached R$505.4 million, a 45.3% increase YoY, and adjusted EBITDA increased 25.9% to R$195.1 million. Afya achieved a cash position of R$748.6 million and a 100.8% cash conversion rate. The company also made strategic acquisitions and plans to continue expanding its medical education offerings, projecting 2022 adjusted net revenue of R$2.28-2.36 billion.
Afya Limited (NASDAQ: AFYA) announced the approval of an additional 28 medical school seats at Centro Universitário São Lucas in Ji-Parana, Rondônia, by the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education. This authorization increases Afya's total approved seats to 2,759, potentially accommodating approximately 19,865 students. The earn-out for this approval amounts to R$800,000 per seat, with payments structured over the next year.
Afya Limited (NASDAQ: AFYA) announced the authorization of two new medical schools under Brazil's Mais Médicos II program, located in Bragança (Pará) and Manacapuru (Amazonas). This expansion adds 100 seats to Afya's operational capacity, increasing the total number of seats to 2,681 out of an approved 2,731. This marks a significant step for Afya in strengthening its position as a leading medical education provider in Brazil.
Afya Limited (NASDAQ: AFYA) has received a binding offer from the Esteves family to sell 6 million Class B common shares at a price of US$26.90 each to Bertelsmann SE & Co. KGaA. This potential transaction would result in Bertelsmann and the Esteves family owning 57.5% and 33.1% voting interest in Afya, respectively. The deal is contingent on due diligence and board approval by Bertelsmann. If completed, it will allow Bertelsmann to consolidate its investment in Afya under International Financial Reporting Standards, indicating a strategic long-term commitment to the company.
Afya Limited (Nasdaq: AFYA) announced the successful acquisition of 100% of Além da Medicina through its subsidiary, Afya Participações S.A. This medical content platform offers valuable resources for physicians and medical students, contributing to Afya's digital ecosystem. With over 4,000 subscribers and a projected gross revenue of R$12.7 million for 2022, Além da Medicina enhances Afya's educational capabilities. The acquisition cost was R$16 million, fully paid in cash, with potential earn-outs of up to R$19.2 million based on performance metrics for 2023 and 2024.
Afya Limited (NASDAQ: AFYA) has announced its acquisition of 100% of Além da Medicina, an online medical content platform, through its subsidiary Afya Participações S.A. This acquisition, valued at R$16.0 million, is subject to customary conditions and involves a potential earn-out of up to R$19.2 million based on revenue targets for 2023 and 2024. Além da Medicina, which projects R$12.7 million in gross revenue for 2022, enhances Afya's digital ecosystem by providing educational tools and resources to medical professionals.
Afya Limited (NASDAQ: AFYA) announces the authorization of two new medical schools in Brazil under the Mais Médicos II program. The schools, located in Abaetetuba (Pará) and Itacoatiara (Amazonas), will each contribute 50 seats, increasing Afya's total operating seats to 2,581 out of 2,731 approved seats. This expansion marks a significant milestone for Afya, cementing its position as a leading medical education group in Brazil.